105 related articles for article (PubMed ID: 19096133)
1. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model.
Ciriza J; Moreno-Igoa M; Calvo AC; Yague G; Palacio J; Miana-Mena FJ; Muñoz MJ; Zaragoza P; Brûlet P; Osta R
Restor Neurol Neurosci; 2008; 26(6):459-65. PubMed ID: 19096133
[TBL] [Abstract][Full Text] [Related]
2. Non-viral gene delivery of the GDNF, either alone or fused to the C-fragment of tetanus toxin protein, prolongs survival in a mouse ALS model.
Moreno-Igoa M; Calvo AC; Ciriza J; Muñoz MJ; Zaragoza P; Osta R
Restor Neurol Neurosci; 2012; 30(1):69-80. PubMed ID: 22124037
[TBL] [Abstract][Full Text] [Related]
3. A glial cell line-derived neurotrophic factor (GDNF):tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice.
Larsen KE; Benn SC; Ay I; Chian RJ; Celia SA; Remington MP; Bejarano M; Liu M; Ross J; Carmillo P; Sah D; Phillips KA; Sulzer D; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2006 Nov; 1120(1):1-12. PubMed ID: 17020749
[TBL] [Abstract][Full Text] [Related]
4. IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice.
Chian RJ; Li J; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Bronson RT; Rossomando A; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2009 Sep; 1287():1-19. PubMed ID: 19563785
[TBL] [Abstract][Full Text] [Related]
5. Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule.
Calvo AC; Moreno-Igoa M; Mancuso R; Manzano R; Oliván S; Muñoz MJ; Penas C; Zaragoza P; Navarro X; Osta R
Orphanet J Rare Dis; 2011 Mar; 6():10. PubMed ID: 21418619
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
7. Insect GDNF:TTC fusion protein improves delivery of GDNF to mouse CNS.
Li J; Chian RJ; Ay I; Kashi BB; Celia SA; Tamrazian E; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Biochem Biophys Res Commun; 2009 Dec; 390(3):947-51. PubMed ID: 19852934
[TBL] [Abstract][Full Text] [Related]
8. Recombinant GDNF: tetanus toxin fragment C fusion protein produced from insect cells.
Li J; Chian RJ; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Remington MP; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Biochem Biophys Res Commun; 2009 Jul; 385(3):380-4. PubMed ID: 19465006
[TBL] [Abstract][Full Text] [Related]
9. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
10. Glial cell line-derived neurotrophic factor protein prevents motor neuron loss of transgenic model mice for amyotrophic lateral sclerosis.
Manabe Y; Nagano I; Gazi MS; Murakami T; Shiote M; Shoji M; Kitagawa H; Abe K
Neurol Res; 2003 Mar; 25(2):195-200. PubMed ID: 12635522
[TBL] [Abstract][Full Text] [Related]
11. Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
Kosuge Y; Sekikawa-Nishida K; Negi H; Ishige K; Ito Y
Neurosci Lett; 2009 Apr; 454(2):165-9. PubMed ID: 19429077
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor facilitates in vivo internalization of tetanus neurotoxin C-terminal fragment fusion proteins in mature mouse motor nerve terminals.
Roux S; Saint Cloment C; Curie T; Girard E; Miana Mena FJ; Barbier J; Osta R; Molgó J; Brûlet P
Eur J Neurosci; 2006 Sep; 24(6):1546-54. PubMed ID: 17004918
[TBL] [Abstract][Full Text] [Related]
13. Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy.
Moreno-Igoa M; Calvo AC; Penas C; Manzano R; Oliván S; Muñoz MJ; Mancuso R; Zaragoza P; Aguilera J; Navarro X; Osta Pinzolas R
J Mol Med (Berl); 2010 Mar; 88(3):297-308. PubMed ID: 19921501
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of supplemental superoxide dismutase on survival of neuronal cells during starvation. Requirement for cytosolic distribution.
Matthews CC; Figueiredo DM; Wollack JB; Fairweather NF; Dougan G; Hallewell RA; Cadet JL; Fishman PS
J Mol Neurosci; 2000 Jun; 14(3):155-66. PubMed ID: 10984191
[TBL] [Abstract][Full Text] [Related]
15. Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy.
Acsadi G; Anguelov RA; Yang H; Toth G; Thomas R; Jani A; Wang Y; Ianakova E; Mohammad S; Lewis RA; Shy ME
Hum Gene Ther; 2002 Jun; 13(9):1047-59. PubMed ID: 12067438
[TBL] [Abstract][Full Text] [Related]
16. Systemic injection of AAV9-GDNF provides modest functional improvements in the SOD1
Thomsen GM; Alkaslasi M; Vit JP; Lawless G; Godoy M; Gowing G; Shelest O; Svendsen CN
Gene Ther; 2017 Apr; 24(4):245-252. PubMed ID: 28276446
[TBL] [Abstract][Full Text] [Related]
17. GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD-1) gene.
Derby ML; Giuliano R; Figlewicz DA; Bohn MC
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Mar; 1(2):113-22. PubMed ID: 11467048
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture.
Carunchio I; Curcio L; Pieri M; Pica F; Caioli S; Viscomi MT; Molinari M; Canu N; Bernardi G; Zona C
Exp Neurol; 2010 Nov; 226(1):218-30. PubMed ID: 20832409
[TBL] [Abstract][Full Text] [Related]
19. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
Pitzer C; Krüger C; Plaas C; Kirsch F; Dittgen T; Müller R; Laage R; Kastner S; Suess S; Spoelgen R; Henriques A; Ehrenreich H; Schäbitz WR; Bach A; Schneider A
Brain; 2008 Dec; 131(Pt 12):3335-47. PubMed ID: 18835867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
